Hoon Yub Kim1, Young Jun Chai2, Gianlorenzo Dionigi3, Angkoon Anuwong4, Jeremy D Richmon5. 1. Department of Surgery, KUMC Thyroid Center, Korea University Hospital, Korea University College of Medicine, 126-1 Anam-dong, Seongbuk-gu, Seoul, 136-705, Korea. hoonyubkim@korea.ac.kr. 2. Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Korea. 3. First Division of Surgery, Research Center for Endocrine Surgery, Department of Surgical Sciences and Human Morphology, University of Insubria (Como-Varese), Varese, Italy. 4. Department of Surgery, Faculty of Medicine, Police General Hospital, Siam University, Bangkok, Thailand. 5. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Transoral thyroid surgery is an ideal method for minimally invasive thyroidectomy, as there is less flap dissection during the procedure and no postoperative scars. Nonetheless, technical obstacles have precluded the wide dissemination of this procedure. We present the surgical procedures and outcomes of transoral robotic thyroidectomy (TORT). METHODS: From September 2012 to June 2016, we performed TORT at Korea University Hospital. We used three intraoral ports and a single axillary port for the system's four robotic arms. The surgical outcomes were retrospectively reviewed. RESULTS: Twenty-four female patients (mean age 39.6 ± 11.6 years; mean tumor size 1.0 ± 1.3 cm) underwent unilateral thyroid lobectomies with or without ipsilateral central neck dissection. Twenty patients had papillary thyroid carcinomas (PTC), three had benign nodules, and one had a follicular thyroid carcinoma. The mean surgical time was 232 ± 41 min; the mean hospital stay was 3.3 ± 0.8 days. The number of retrieved central lymph nodes in the PTC patients was 4.7 ± 3.2. There were no reports of transient or permanent vocal cord palsy, recurrence, or mortality during the median follow-up period of 16.8 months. Paresthesia of the lower lip and the chin due to mental nerve injury was observed in nine of the first 12 patients (six transient, three permanent), but no further reports of paresthesia were recorded after patient 12, when the locations of the intraoral incisions were modified. CONCLUSIONS: TORT is feasible and safe for selected patients after technical refinements, and can be a potential alternative approach for scarless thyroid surgery.
BACKGROUND: Transoral thyroid surgery is an ideal method for minimally invasive thyroidectomy, as there is less flap dissection during the procedure and no postoperative scars. Nonetheless, technical obstacles have precluded the wide dissemination of this procedure. We present the surgical procedures and outcomes of transoral robotic thyroidectomy (TORT). METHODS: From September 2012 to June 2016, we performed TORT at Korea University Hospital. We used three intraoral ports and a single axillary port for the system's four robotic arms. The surgical outcomes were retrospectively reviewed. RESULTS: Twenty-four female patients (mean age 39.6 ± 11.6 years; mean tumor size 1.0 ± 1.3 cm) underwent unilateral thyroid lobectomies with or without ipsilateral central neck dissection. Twenty patients had papillary thyroid carcinomas (PTC), three had benign nodules, and one had a follicular thyroid carcinoma. The mean surgical time was 232 ± 41 min; the mean hospital stay was 3.3 ± 0.8 days. The number of retrieved central lymph nodes in the PTCpatients was 4.7 ± 3.2. There were no reports of transient or permanent vocal cord palsy, recurrence, or mortality during the median follow-up period of 16.8 months. Paresthesia of the lower lip and the chin due to mental nerve injury was observed in nine of the first 12 patients (six transient, three permanent), but no further reports of paresthesia were recorded after patient 12, when the locations of the intraoral incisions were modified. CONCLUSIONS: TORT is feasible and safe for selected patients after technical refinements, and can be a potential alternative approach for scarless thyroid surgery.
Authors: Hye Yoon Lee; Jeremy D Richmon; Rohan R Walvekar; Christopher Holsinger; Hoon Yub Kim Journal: J Laparoendosc Adv Surg Tech A Date: 2015-01-28 Impact factor: 1.878
Authors: Jeremy D Richmon; F Christopher Holsinger; Emad Kandil; Michael W Moore; Jose Armando Garcia; Ralph P Tufano Journal: J Robot Surg Date: 2011-06-15
Authors: Young Jun Chai; Junho Song; Jiyoung Kang; Jung-Woo Woo; Ra-Yeong Song; Hyungju Kwon; Su-Jin Kim; June Young Choi; Kyu Eun Lee Journal: Ann Surg Treat Res Date: 2016-05-02 Impact factor: 1.859
Authors: Hong Kyu Kim; Young Jun Chai; Gianlorenzo Dionigi; Eren Berber; Ralph P Tufano; Hoon Yub Kim Journal: World J Surg Date: 2019-04 Impact factor: 3.352
Authors: Jonathon O Russell; Christopher R Razavi; Mohammad Shaear; Lena W Chen; Andrew H Lee; Rohit Ranganath; Ralph P Tufano Journal: J Clin Endocrinol Metab Date: 2019-03-12 Impact factor: 5.958
Authors: Jonathon O Russell; Christopher R Razavi; Meghan E Garstka; Lena W Chen; Elya Vasiliou; Sang-Wook Kang; Ralph P Tufano; Emad Kandil Journal: J Am Coll Surg Date: 2018-12-23 Impact factor: 6.113
Authors: Christopher R Razavi; Mai G Al Khadem; Akeweh Fondong; James H Clark; Jeremy D Richmon; Ralph P Tufano; Jonathon O Russell Journal: Head Neck Date: 2018-05-13 Impact factor: 3.147